Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
July 11, 2024 8:47 AM 2 min read

Costco To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Thursday

by Avi Kapoor Benzinga Staff Writer
Follow

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • Morgan Stanley cut the price target for Microchip Technology Incorporated (NASDAQ:MCHP) from $102 to $100. Morgan Stanley analyst Joseph Moore downgraded the stock from Overweight to Equal-Weight. Microchip Technology shares rose 3.9% to close at $95.98 on Wednesday. See how other analysts view this stock.
  • Truist Securities lifted the price target for Astrana Health, Inc. (NASDAQ:ASTH) from $44 to $50. Truist Securities analyst Jailendra Singh upgraded the stock from Hold to Buy. Astrana Health shares fell 0.4% to close at $38.20 on Wednesday. See how other analysts view this stock.
  • Baird boosted the price target for Costco Wholesale Corporation (NASDAQ:COST) from $850 to $975. Baird analyst Peter Benedict maintained an Outperform rating. Costco shares fell 0.3% to close at $884.31 on Wednesday. See how other analysts view this stock.
  • Wedbush increased CAVA Group, Inc. (NYSE:CAVA) price target from $90 to $100. Wedbush analyst Nick Setyan maintained an Outperform rating. CAVA shares fell 5.5% to close at $85.30 on Wednesday. See how other analysts view this stock.
  • Guggenheim boosted the price target for Dutch Bros Inc. (NYSE:BROS) from $30 to $36. Guggenheim analyst Gregory Francfort maintained a Neutral rating. Dutch Bros shares fell 4.3% to close at $39.46 on Wednesday. See how other analysts view this stock.
  • Keybanc cut Phreesia, Inc. (NYSE:PHR) price target from $27 to $25. Keybanc analyst Scott Schoenhaus maintained an Overweight. Phreesia shares fell 7% to close at $18.82 on Wednesday. See how other analysts view this stock.
  • Piper Sandler increased Kimberly-Clark Corporation (NYSE:KMB) price target from $167 to $174. Piper Sandler analyst Korinne Wolfmeyer maintained an Overweight rating. Kimberly-Clark shares gained 1% to close at $140.79 on Wednesday. See how other analysts view this stock.
  • Leerink Partners raised Lantheus Holdings, Inc. (NASDAQ:LNTH) price target from $106 to $127. Leerink Partners maintained an Outperform rating. Lantheus shares jumped 36.7% to close at $106.18 on Wednesday. See how other analysts view this stock.
  • Baird boosted Sprouts TaskUs, Inc. (NASDAQ:TASK) price target from $14 to $16. Baird analyst David Koning maintained an Outperform rating. TaskUs shares gained 3.1% to close at $14.54 on Wednesday. See how other analysts view this stock.
  • HC Wainwright & Co. raised Annovis Bio, Inc. (NYSE:ANVS) price target from $23 to $30. HC Wainwright & Co. analyst Raghuram Selvaraju maintained a Buy rating. Annovis Bio shares fell 17.1% to close at $12.08 on Wednesday. See how other analysts view this stock.

Check This Out:

  • Top 4 Real Estate Stocks That Could Lead To Your Biggest Gains In Q3
Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
NewsPrice TargetMarketsAnalyst RatingsTrading Ideasanalyst forecastsPT Changes
COST Logo
COSTCostco Wholesale Corp
$981.11-2.55%
Overview
ANVS Logo
ANVSAnnovis Bio Inc
$2.58-4.45%
ASTH Logo
ASTHAstrana Health Inc
$24.87-2.81%
BROS Logo
BROSDutch Bros Inc
$53.481.47%
CAVA Logo
CAVACava Group Inc
$79.01-0.64%
KMB Logo
KMBKimberly-Clark Corp
$103.93-0.76%
LNTH Logo
LNTHLantheus Holdings Inc
$75.45-3.07%
MCHP Logo
MCHPMicrochip Technology Inc
$69.31-0.84%
PHR Logo
PHRPhreesia Inc
$12.82-3.64%
TASK Logo
TASKTaskUs Inc
$11.431.60%
COST Logo
COSTCostco Wholesale Corp
$981.11-2.55%
Overview
ANVS Logo
ANVSAnnovis Bio Inc
$2.58-4.45%
ASTH Logo
ASTHAstrana Health Inc
$24.87-2.81%
BROS Logo
BROSDutch Bros Inc
$53.481.47%
CAVA Logo
CAVACava Group Inc
$79.01-0.64%
KMB Logo
KMBKimberly-Clark Corp
$103.93-0.76%
LNTH Logo
LNTHLantheus Holdings Inc
$75.45-3.07%
MCHP Logo
MCHPMicrochip Technology Inc
$69.31-0.84%
PHR Logo
PHRPhreesia Inc
$12.82-3.64%
TASK Logo
TASKTaskUs Inc
$11.431.60%
Comments
Loading...